Moreover, post-natal administration of L. johnsonii in T1D-prone rats was reported to regulate the structure of the intestinal barrier, reducing intestinal inflammation by increasing the expression of claudin-1 and decreasing the expression of occludin [72]. The gene discussed is CLDN1; the disease is type 1 diabetes mellitus.